We regularly have new studies that we are recruiting for. If you don’t see something that you qualify for right now, please call Caitlin at 952-993-9605 to be contacted about future studies.
Feasibility Study with Personalized Closed Loop (PCL) (Medtronic 326)
Principal Investigator: Anders Carlson, MD
Study Sponsor: Medtronic MiniMed, Inc.
Location: International Diabetes Center
Purpose of study: Continuous glucose monitoring (CGM), including insulin pumps that use CGM, has been helpful for many people with diabetes. Improvements have been made to these systems in recent years, letting insulin pumps adjust how much insulin they give based on information from sensors inserted under the skin. These systems still need the individual to tell the pump when they are eating meals and to give insulin for these meals. Researchers are working on making these systems even more automatic. This may reduce how much a person needs to do to actively manage their treatment and increase how much time a person stays in an ideal blood glucose range.
• This study will be testing new software in a Minimed insulin pump that is not yet commercially available.
• New software will be used as part of this insulin pump system to make personalized recommendations for changes in pump settings that adjust the amount of insulin a person receives throughout the day
• New software will be used via a phone app that can predict when usual meals are eaten.
Inclusion Criteria: The study is accepting individuals ages 18-80 who:
• Have had type 1 diabetes for at least 1 year
• Are willing to use the insulin pump system throughout the study
• Meet other study specific criteria
Study Contact:
Caitlin Hasledalen
(952) 993-9605
IDCResearch@parknicollet.com
Omnipod Horizon™ Automated Glucose Control System Preschool Cohort
Principal Investigator: Amy Criego, MD
Study Sponsor: Insulet Corporation
Location: International Diabetes Center
Purpose of study: C=This study will be testing a new insulin pump system called the Omnipod Horizon™ Automated Insulin Delivery System. The study is being done to find out how well the insulin pump system works to automatically infuse insulin for control of glucose levels in children with type 1 diabetes. The system consists of a tubeless pump (pod), the Omnipod Horizon™ Personal Diabetes Manager (PDM), and the Dexcom G6 Continuous Glucose Monitoring System® (CGM).
Inclusion Criteria: The study is accepting children ages 2 through 5 who:
• Have type 1 diabetes
• Have an A1C less than 10%
• Are willing to use the insulin pump system throughout the study
Study Contact:
Caitlin Hasledalen
(952) 993-9605
IDCResearch@parknicollet.com
Comparison of Glucose Values and Variability Between TOUJEO and TRESIBA During Continuous Glucose Monitoring in Type 1 Diabetes Patients (inRange)
Principal Investigator: Richard Bergenstal, MD
Study Sponsor: Sanofi
Location: International Diabetes Center
Purpose of study: This study will compare how two different FDA approved long acting insulins work for people with type 1 diabetes. Participants will be provided with either insulin Tuojeo and Tresiba throughout the study to take in addition to their rapid acting insulin. Continuous glucose monitoring (CGM) will be used to measure glucose levels.
Inclusion Criteria: The study is accepting males and females ages 18-70 who:
• Have type 1 diabetes
• Take multiple daily insulin injections for their diabetes
• Have an A1C between 7.0-10.0%
• Meet other study specific requirements
Study Contact:
Caitlin Hasledalen
(952) 993-9605
IDCResearch@parknicollet.com
